
    
      Patients with end-stage renal disease receiving or about to initiate hemodialysis are
      randomized to receive either adjusted dose warfarin to achieve an INR of 1.5-1.9 or adjusted
      dose placebo within 72 hours of hemodialysis catheter placement. The primary outcome is
      mechanical failure of the catheter, as outlined below.
    
  